Cottonwood Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$765K Hold
5,954
0.46% 41
2026
Q1
$716K Hold
5,954
0.51% 42
2025
Q4
$627K Hold
5,954
0.45% 47
2025
Q3
$500K Sell
5,954
-221
-4% -$18.2K 0.36% 57
2025
Q2
$489K Buy
6,175
+46
+0.8% +$3.66K 0.33% 64
2025
Q1
$550K Hold
6,129
0.4% 55
2024
Q4
$610K Sell
6,129
-78
-1% -$8.04K 0.44% 52
2024
Q3
$705K Sell
6,207
-142
-2% -$16.9K 0.52% 48
2024
Q2
$800K Sell
6,349
-39
-0.6% -$5.02K 0.63% 40
2024
Q1
$806K Sell
6,388
-30
-0.5% -$3.7K 0.64% 42
2023
Q4
$700K Sell
6,418
-102
-2% -$10.6K 0.58% 45
2023
Q3
$671K Sell
6,520
-110
-2% -$11.9K 0.63% 44
2023
Q2
$765K Sell
6,630
-143
-2% -$16.2K 0.7% 39
2023
Q1
$721K Sell
6,773
-45
-0.7% -$4.86K 0.66% 42
2022
Q4
$756K Sell
6,818
-252
-4% -$25.8K 0.68% 41
2022
Q3
$609K Sell
7,070
-3
-0% -$268 0.58% 45
2022
Q2
$645K Sell
7,073
-50
-0.7% -$4.43K 0.58% 46
2022
Q1
$584K Sell
7,123
-308
-4% -$24.3K 0.46% 52
2021
Q4
$570K Buy
+7,431
New +$592K 0.44% 52

Other funds holding MRK

Cottonwood Capital Advisors's MRK Position: Q2 2026 in Review

Cottonwood Capital Advisors held its Merck (MRK) position steady in Q2 2026 at 5,954 shares worth $765K. The position accounts for 0.46% of the portfolio, ranked #41.

Cottonwood Capital Advisors first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $806K in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cottonwood Capital Advisors held 5,954 shares of Merck worth $765K as of Q2 2026.
  • Cottonwood Capital Advisors left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.46% of Cottonwood Capital Advisors's portfolio in Q2 2026, its #41 holding.
  • Cottonwood Capital Advisors first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • Cottonwood Capital Advisors's Merck position peaked at $806K in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cottonwood Capital Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.